Risultati per: Linee guida sul melanoma cutaneo

This case series describes a constellation of novel adverse reactions in 3 of 9 patients with uveal melanoma receiving treatment targeting activity of the Brahma-associated factor chromatin remodeling complex.

This qualitative and survey-based study uses interviews and surveys to understand the psychological well-being of survivors of localized cutaneous melanoma.

This pooled analysis of 6 clinical trials describes the safety and efficacy of different courses of immune checkpoint inhibitor treatment in a neoadjuvant setting among patients with high-risk resectable melanoma.